Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronateManuel Muñoz-Torres
Bone Metabolic Unit, Endocrinology Division, University Hospital San Cecilio, Granada, Spain
Maturitas 64:188-92. 2009
..Measurement of circulating levels of cathepsin K may be useful to assay the number or function of osteoclasts...
- [Medical treatment of primary hyperparathyroidism: role of calcimimetics]
Manuel Muñoz Torres
Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
Endocrinol Nutr 56:29-34. 2009
..The exact role of calcimimetics in the overall management of PHPT is promising and should be considered in future clinical practice guidelines...
- [Hypophosphatasia: new therapeutic approaches]
Guillermo Alonso
Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
Med Clin (Barc) 132:108-11. 2009
....
Lactose intolerance revealed by severe resistance to treatment with levothyroxineManuel Muñoz-Torres
Department of Endocrinology, Hospital Universitario San Cecilio de Granada, Granada, Spain
Thyroid 16:1171-3. 2006
..The possibility of correcting this disorder with simple dietary measures justifies its consideration...
- Calcitonin therapy in osteoporosis
Manuel Muñoz-Torres
Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
Treat Endocrinol 3:117-32. 2004
....
- [Advances in ostheochlast biology: the osteoprotegerin-RANK ligand system]
Manuel Muñoz-Torres
Unidad de Metabolismo Oseo Servicio de Endocrinología y Nutrición Hospital Universitario San Cecilio Granada España
Med Clin (Barc) 122:75-7. 2004
..osteopetrosis) in animal models. Further studies with these factors will provide the development of drugs to treat osteoporosis and other metabolic bone diseases...
- Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors
Pedro Mezquita-Raya
Endocrinology Division, Hospital Torrecardenas, Almeria, Spain
Calcif Tissue Int 75:373-9. 2004
..Our study shows that COLIA1 Sp1 polymorphism, S-25OHD and s-IGF-I serum levels and physical activity are independently associated with BMD in postmenopausal Spanish women...
- [Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity]
Pedro Mezquita Raya
Area de Metabolismo Oseo, , Hospital Universitario San Cecilio, Granada, Spain
Med Clin (Barc) 119:85-9. 2002
..CONCLUSIONS: In populations at risk of osteoporosis, there is a high prevalence of vitamin D insufficiency. This insufficiency has a significant effect on bone integrity...
- Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study
Manuel Sosa
University of Las Palmas de Gran Canaria, Investigation Group on Osteoporosis, Hospital University Insular, Bone Metabolic Unit, Las Palmas de Gran Canaria, Canary Islands, Spain
Aging Clin Exp Res 21:27-32. 2009
..Type 2 diabetes mellitus (DM) has a high prevalence in aging obese postmenopausal women. It is not clear whether or not diabetes produces an increase in bone mineral density or an increase in fracture rates...
- Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis
Rebeca Reyes-García
Bone Metabolic Unit, Endocrinology Division, San Cecilio University Hospital, Granada, Spain
Menopause 17:140-4. 2010
....
